Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
761.930.02%
QQQ
707.830.03%
BTC/USD
77314.780.1005%
DIA
527.670.02%
GLD
396.500.06%
TLT
81.830.05%

KORU Medical Systems Inc

KRMDNASDAQ
Trade with Public
Trade with Public
$3.30
N/A
Last update: Sep 1, 4:25 PM
$3.30
N/A
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

KORU Medical Systems Analyst Price Targets

Wall Street analyst price targets and consensus rating for KORU Medical Systems (KRMD).

Price Target Range — 10 Quarters

Analyst Consensus — 5 Analysts

4Buy
1Hold
Consensus RatingBuy# Analysts5Avg. Consensus PT$6Upside to Avg. PT+75.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Mar 13, 2026Canaccord GenuityCaitlin RobertsMaintainedBuy$6
Mar 13, 2026B. Riley SecuritiesWilliam WoodsPT RaiseBuy$7→$8
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
B. Riley Securities Maintains Buy on KORU Medical Systems, Raises Price Target to $8

B. Riley Securities analyst William Woods maintains KORU Medical Systems (NASDAQ:KRMD) with a Buy and raises the price target from $7 to $8.
Benzinga Newsdesk

PRO
Lake Street Maintains Buy on KORU Medical Systems, Raises Price Target to $8

Lake Street analyst Frank Takkinen maintains KORU Medical Systems (NASDAQ:KRMD) with a Buy and raises the price target from $6 to $8.
Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on KORU Medical Systems, Raises Price Target to $6

Canaccord Genuity analyst Caitlin Roberts maintains KORU Medical Systems (NASDAQ:KRMD) with a Buy and raises the price target from $5 to $6.
Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on KORU Medical Systems, Lowers Price Target to $3.5

Piper Sandler analyst Jason Bednar maintains KORU Medical Systems (NASDAQ:KRMD) with a Neutral and lowers the price target from $4.5 to $3.5.
Benzinga Newsdesk

This Informatica Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Avi Kapoor

PRO
Piper Sandler Downgrades KORU Medical Systems to Neutral, Maintains Price Target to $4.5

Piper Sandler analyst Jason Bednar downgrades KORU Medical Systems (NASDAQ:KRMD) from Overweight to Neutral and maintains the price target from $4.5 to $4.5.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved